| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2021 | SPECTRADYNE LLC | 2501 CHERRY AVE STE 140 | SIGNAL HILL | CA | 90755-2068 | LOS ANGELES | USA | R44TR003256 | Quantifying Specific Nanoparticle Phenotypes in Complex Biological Fluids by Fluorescence Microfluidic Resistive Pulse Sensing. | 000 | 3 | NIH | 3/22/2024 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $820,080 ) |
| | 2021 | 2021 | SPECTRADYNE LLC | 2501 CHERRY AVE STE 140 | SIGNAL HILL | CA | 90755-2068 | LOS ANGELES | USA | R44TR003256 | Quantifying Specific Nanoparticle Phenotypes in Complex Biological Fluids by Fluorescence Microfluidic Resistive Pulse Sensing. | 001 | 3 | NIH | 5/14/2021 | $820,080 |
| | 2021 | 2020 | SPECTRADYNE LLC | 2501 CHERRY AVE STE 140 | SIGNAL HILL | CA | 90755-2068 | LOS ANGELES | USA | R44TR003256 | Quantifying Specific Nanoparticle Phenotypes in Complex Biological Fluids by Fluorescence Microfluidic Resistive Pulse Sensing. | 000 | 1 | NIH | 3/3/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $1,085,374 ) |
| | 2020 | 2020 | SPECTRADYNE LLC | 23875 MADISON ST STE A | TORRANCE | CA | 90505-6008 | LOS ANGELES | USA | R44TR003256 | Quantifying Specific Nanoparticle Phenotypes in Complex Biological Fluids by Fluorescence Microfluidic Resistive Pulse Sensing. | 000 | 1 | NIH | 4/1/2020 | $251,987 |
| | 2020 | 2020 | SPECTRADYNE LLC | 23875 MADISON ST STE A | TORRANCE | CA | 90505-6008 | LOS ANGELES | USA | R44TR003256 | Quantifying Specific Nanoparticle Phenotypes in Complex Biological Fluids by Fluorescence Microfluidic Resistive Pulse Sensing. | 001 | 1 | NIH | 7/22/2020 | $0 |
| | 2020 | 2020 | SPECTRADYNE LLC | 23875 MADISON ST STE A | TORRANCE | CA | 90505-6008 | LOS ANGELES | USA | R44TR003256 | Quantifying Specific Nanoparticle Phenotypes in Complex Biological Fluids by Fluorescence Microfluidic Resistive Pulse Sensing. | 002 | 2 | NIH | 7/24/2020 | $833,387 |
|
| Issue Date FY: 2019 ( Subtotal = $0 ) |
| | 2019 | 2016 | SPECTRADYNE LLC | 23875 MADISON ST STE A | TORRANCE | CA | 90505-6008 | LOS ANGELES | USA | R44EB019271 | Direct detection of nanoparticles in blood: a novel diagnostic for Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) | 000 | 3 | NIH | 12/19/2018 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $731,678 ) |
| | 2016 | 2016 | SPECTRADYNE LLC | 15 FERNCREEK DR | ROLLING HILLS ESTATES | CA | 90274 | LOS ANGELES | USA | R44EB019271 | Direct detection of nanoparticles in blood: a novel diagnostic for Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) | 000 | 3 | NIH | 8/8/2016 | $731,678 |
|
| Issue Date FY: 2015 ( Subtotal = $780,515 ) |
| | 2015 | 2015 | SPECTRADYNE LLC | 15 FERNCREEK DR | ROLLING HILLS ESTATES | CA | 90274 | LOS ANGELES | USA | R43EB019271 | Low cost electronic detection of molecular aggregation for rapid drug development | 002 | 1 | NIH | 9/22/2015 | $0 |
| | 2015 | 2015 | SPECTRADYNE LLC | 15 FERNCREEK DR | ROLLING HILLS ESTATES | CA | 90274 | LOS ANGELES | USA | R43EB019271 | Low cost electronic detection of molecular aggregation for rapid drug development | 000 | 1 | NIH | 8/31/2015 | $27,500 |
| | 2015 | 2015 | SPECTRADYNE LLC | 15 FERNCREEK DR | ROLLING HILLS ESTATES | CA | 90274 | LOS ANGELES | USA | R44EB019271 | Direct detection of nanoparticles in blood: a novel diagnostic for Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) | 000 | 2 | NIH | 9/25/2015 | $753,015 |
| | 2015 | 2014 | SPECTRADYNE LLC | 15 FERNCREEK DR | ROLLING HILLS ESTATES | CA | 90274 | LOS ANGELES | USA | R43EB019271 | Low cost electronic detection of molecular aggregation for rapid drug development | 001 | 1 | NIH | 9/22/2015 | $0 |
|
| Issue Date FY: 2014 ( Subtotal = $213,490 ) |
| | 2014 | 2014 | SPECTRADYNE LLC | 15 FERNCREEK DR | ROLLING HILLS ESTATES | CA | 90274 | LOS ANGELES | USA | R43EB019271 | Low cost electronic detection of molecular aggregation for rapid drug development | 000 | 1 | NIH | 9/25/2014 | $213,490 |
|
|
